BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38594369)

  • 1. Design and methods of the mobile assessment of cognition, environment, and sleep (MACES) feasibility study in newly diagnosed breast cancer patients.
    Derbes R; Hakun J; Elbich D; Master L; Berenbaum S; Huang X; Buxton OM; Chang AM; Truica CI; Sturgeon KM
    Sci Rep; 2024 Apr; 14(1):8338. PubMed ID: 38594369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Examination of the Longitudinal Relationship Between Cognitive Function and Physical Activity Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study.
    Tometich DB; Mosher CE; Cyders M; McDonald BC; Saykin AJ; Small BJ; Zhai W; Zhou X; Jim HSL; Jacobsen P; Ahles TA; Root JC; Graham D; Patel SK; Mandelblatt J
    Ann Behav Med; 2023 Apr; 57(3):237-248. PubMed ID: 36356044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between endocrine therapy and cognitive decline in older women with early breast cancer: Findings from the prospective CLIMB study.
    Baltussen JC; Derks MGM; Lemij AA; de Glas NA; Fiocco M; Linthorst-Niers EMH; Vulink AJE; van Gerven L; Guicherit OR; van Dalen T; Merkus JWS; Lans TE; van der Pol CC; Mooijaart SP; Portielje JEA; Liefers GJ
    Eur J Cancer; 2023 May; 185():1-10. PubMed ID: 36933518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of EEG biofeedback on reducing postcancer cognitive impairment.
    Alvarez J; Meyer FL; Granoff DL; Lundy A
    Integr Cancer Ther; 2013 Nov; 12(6):475-87. PubMed ID: 23584550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light-enhanced cognitive behavioural therapy for sleep and fatigue: study protocol for a randomised controlled trial during chemotherapy for breast cancer.
    Bean HR; Stafford L; Little R; Diggens J; Ftanou M; Alexander M; Francis PA; Bei B; Wiley JF
    Trials; 2020 Mar; 21(1):295. PubMed ID: 32216832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol for Exercise Program in Cancer and Cognition (EPICC): A randomized controlled trial of the effects of aerobic exercise on cognitive function in postmenopausal women with breast cancer receiving aromatase inhibitor therapy.
    Gentry AL; Erickson KI; Sereika SM; Casillo FE; Crisafio ME; Donahue PT; Grove GA; Marsland AL; Watt JC; Bender CM
    Contemp Clin Trials; 2018 Apr; 67():109-115. PubMed ID: 29501739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series.
    Galantino ML; Greene L; Daniels L; Dooley B; Muscatello L; O'Donnell L
    Explore (NY); 2012; 8(2):127-35. PubMed ID: 22385567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of Using a Wearable Biosensor Device in Patients at Risk for Alzheimer's Disease Dementia.
    Saif N; Yan P; Niotis K; Scheyer O; Rahman A; Berkowitz M; Krikorian R; Hristov H; Sadek G; Bellara S; Isaacson RS
    J Prev Alzheimers Dis; 2020; 7(2):104-111. PubMed ID: 32236399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The promise of wearable sensors and ecological momentary assessment measures for dynamical systems modeling in adolescents: a feasibility and acceptability study.
    Brannon EE; Cushing CC; Crick CJ; Mitchell TB
    Transl Behav Med; 2016 Dec; 6(4):558-565. PubMed ID: 27678501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chatbot-interfaced and cognitive-affective barrier-driven messages to improve colposcopy adherence after abnormal Pap test results in underserved urban women: A feasibility pilot study.
    Wen KY; Dayaratna S; Slamon R; Granda-Cameron C; Tagai EK; Kohler RE; Hudson SV; Miller SM
    Transl Behav Med; 2024 Jan; 14(1):1-12. PubMed ID: 38014626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cognitive effects of endocrine therapy in survivors of breast cancer: A prospective longitudinal study up to 6 years after treatment.
    Van Dyk K; Crespi CM; Bower JE; Castellon SA; Petersen L; Ganz PA
    Cancer; 2019 Mar; 125(5):681-689. PubMed ID: 30485399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remote Evaluation of Sleep and Circadian Rhythms in Older Adults With Mild Cognitive Impairment and Dementia: Protocol for a Feasibility and Acceptability Mixed Methods Study.
    Gabb VG; Blackman J; Morrison HD; Biswas B; Li H; Turner N; Russell GM; Greenwood R; Jolly A; Trender W; Hampshire A; Whone A; Coulthard E
    JMIR Res Protoc; 2024 Mar; 13():e52652. PubMed ID: 38517469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of anastrozole on cognitive performance in postmenopausal women: a randomised, double-blind chemoprevention trial (IBIS II).
    Jenkins VA; Ambroisine LM; Atkins L; Cuzick J; Howell A; Fallowfield LJ
    Lancet Oncol; 2008 Oct; 9(10):953-61. PubMed ID: 18768369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily collection of self-reporting sleep disturbance data via a smartphone app in breast cancer patients receiving chemotherapy: a feasibility study.
    Min YH; Lee JW; Shin YW; Jo MW; Sohn G; Lee JH; Lee G; Jung KH; Sung J; Ko BS; Yu JH; Kim HJ; Son BH; Ahn SH
    J Med Internet Res; 2014 May; 16(5):e135. PubMed ID: 24860070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer.
    Stein RC; Dunn JA; Bartlett JM; Campbell AF; Marshall A; Hall P; Rooshenas L; Morgan A; Poole C; Pinder SE; Cameron DA; Stallard N; Donovan JL; McCabe C; Hughes-Davies L; Makris A;
    Health Technol Assess; 2016 Feb; 20(10):xxiii-xxix, 1-201. PubMed ID: 26867046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of cognitive function, sleep and activity levels in disease-free breast cancer patients with or without cancer-related fatigue syndrome.
    Minton O; Stone PC
    BMJ Support Palliat Care; 2012 Sep; 2(3):231-8. PubMed ID: 23585925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.